Bhavesh Mohan Lal, MD, UAMS College of Medicine, Little Rock, Arkansas, reviews a study designed to investigate the effects of prior exposure to BCMA-targeting agents on outcomes with…
Praneeth Reddy Sudalagunta, PhD, applied research scientist, Moffitt Cancer Center, Tampa, Florida, discusses the differential effects of bridging therapy on the immune microenvironment as well as outcomes with…
Dr. Christine Lau at the University of Virginia Health System goes over treatment options for early and late stage esophageal cancer. References and Resources Daly, J., et al.…
Christine L. Lau, MD, Assistant Professor of Surgery, University of Virginia Health System, Charlottesville, VA, goes over the procedure for diagnosing and treating esophageal cancer. References and Resources…
Pamela J. Paley, MD, Gynelcologic Oncologist, Swedish Cancer Institute, Seattle, WA, discusses minimally invasive surgery in gynecologic cancer. References and Resources Zakashansky K, Bradley WH, Nezhat FR. New…
Brenda J. Hoffman, MD, Professor, Division of Gastroenterology, Medical University of South Carolina, Charleston, SC, discusses colon cancer screening in the African-American population. References and Resources Sharma S,…
Christine L. Lau, MD, Assistant Professor of Surgery, Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia Health System, Charlottesville, VA, discusses the statistics of…
According to a small multi-center, phase II trial reported in NEJM, an investigational targeted drug for some patients with metastatic thyroid cancer can induce partial responses. References and…
The tumor-derived vaccine vitespen (Oncophage) does not prevent renal-cell carcinoma recurrence or improve survival despite promising early results. References and Resources Wood C, Srivastava P, Bukowski R, et…
Nancy A. Kernan, MD, Assistant Chief, Pediatric Bone Marrow Service, Director, Unrelated Donor Program, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the importance of SuperSibs!, a national…
At the American Society of Clinical Oncology meeting, data from a small retrospective analysis suggest that diabetic patients with breast cancer had significantly higher rates of response to…
Douglas S. Hawkins, MD, Associate Professor, Pediatrics, Children’s Hospital and regional Medical Center, Seattle WA, discusses pharmacogenomics of chemotherapy. For more information on this physician visit: SeattleChildrens.org .
